Biotech · Private company
Lantheus Biosciences Ltd.
Track this companyFree. Adds Lantheus Biosciences Ltd. to your Dealase workspace and tells you when its record changes.
Clinical trials41 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- [18F]PI-2620Phase 3 · Alzheimer DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- Florbetaben (BAY94-9172)Phase 3 · Alzheimer DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- BAY94-9392Phase 1 · Diagnostic ImagingClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials4
- [18F]PI-2620 Phase 3 Histopathological StudyPHASE3 · RECRUITING · started Dec 1, 2022ClinicalTrials.gov NCT05641688 · fetched Nov 12, 2026
- Radiation Dosimetry, Metabolism, Pharmacokinetics, Safety and Tolerability and PET Imaging With BAY94-9392 in Healthy Volunteers and Patients With Cancer or InflammationPHASE1 · COMPLETED · started Apr 1, 2010ClinicalTrials.gov NCT01103310 · fetched Nov 12, 2026
- Phase III Study of Florbetaben (BAY94-9172) PET Imaging for Detection/Exclusion of Cerebral β-amyloid Compared to HistopathologyPHASE3 · COMPLETED · started Nov 1, 2009ClinicalTrials.gov NCT01020838 · fetched Nov 12, 2026
- Phase II Study of Florbetaben (BAY 94-9172) PET Imaging for Detection/Exclusion of Cerebral β-amyloid in Patients With Probable Alzheimer's Disease Compared to Healthy VolunteersPHASE2 · COMPLETED · started Aug 1, 2008ClinicalTrials.gov NCT00750282 · fetched Nov 12, 2026